Stay updated on IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s IPD Sharing revision indicator was updated from v3.6.2 to v3.6.3, reflecting a small documentation update.
    Difference
    0.1%
    Check dated 2026-07-05T04:38:08.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.6.2 is now displayed on the page, signaling a software or content update. The study details and available information remain the same.
    Difference
    0.1%
    Check dated 2026-06-27T23:19:51.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention / Treatment header was changed to Intervention/Treatment. The footer revision label was updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T16:44:57.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A new Revision: v3.5.5 entry was added along with updated dates (2026-05-18, 2026-06-01, 2027-02-01). Older entries corresponding to Revision: v3.5.4 and dates like 2025-05-15 and 2025-05-14 were removed from the study record dates.
    Difference
    0.3%
    Check dated 2026-06-06T12:25:07.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a new revision entry (v3.5.4) and removes the previous revision (v3.5.3), indicating a minor update to the page's revision history rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-05-15T23:52:31.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page’s interface release/version stamp is updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a software/template update without changing the underlying trial information.
    Difference
    0.1%
    Check dated 2026-04-24T06:17:25.000Z thumbnail image

Stay in the know with updates to IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.